Jiao B - Search Results

1

Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.

Basu A, Winn AN, Johnson KM, Jiao B, Devine B, Hankins JS, Arnold SD, Bender MA, Ramsey SD. Basu A, et al. Among authors: jiao b. Ann Intern Med. 2024 Feb;177(2):155-164. doi: 10.7326/M23-1520. Epub 2024 Jan 23. Ann Intern Med. 2024. PMID: 38252942

2

The use of real-world evidence in ICER's scoping process and clinical evidence assessments.

Jiao B, Veenstra DL, Lee W, Carlson JJ, Devine B. Jiao B, et al. J Manag Care Spec Pharm. 2020 Dec;26(12):1590-1595. doi: 10.18553/jmcp.2020.26.12.1590. J Manag Care Spec Pharm. 2020. PMID: 33251999 Free PMC article.

3

Use of real-world evidence in economic assessments of pharmaceuticals in the United States.

Lee W, Dayer V, Jiao B, Carlson JJ, Devine B, Veenstra DL. Lee W, et al. Among authors: jiao b. J Manag Care Spec Pharm. 2021 Jan;27(1):5-14. doi: 10.18553/jmcp.2021.27.1.005. J Manag Care Spec Pharm. 2021. PMID: 33377439 Free PMC article.

4

Catalog of Age- and Medical Condition-Specific Healthcare Costs in the United States to Inform Future Costs Calculations in Cost-Effectiveness Analysis.

Jiao B, Basu A. Jiao B, et al. Value Health. 2021 Jul;24(7):957-965. doi: 10.1016/j.jval.2021.03.006. Epub 2021 Apr 24. Value Health. 2021. PMID: 34243839 Free article.

5

The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature.

Jiao B, Basu A, Roth J, Bender M, Rovira I, Clemons T, Quach D, Ramsey S, Devine B. Jiao B, et al. Pharmacoeconomics. 2021 Nov;39(11):1225-1241. doi: 10.1007/s40273-021-01072-z. Epub 2021 Aug 9. Pharmacoeconomics. 2021. PMID: 34368937 Free PMC article. Review.

6

Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review.

Jiao B, Basu A, Ramsey S, Roth J, Bender MA, Quach D, Devine B. Jiao B, et al. Value Health. 2022 Feb;25(2):276-287. doi: 10.1016/j.jval.2021.08.002. Epub 2021 Sep 4. Value Health. 2022. PMID: 35094801 Free PMC article.

7

A landscape analysis and discussion of value of gene therapies for sickle cell disease.

Quach D, Jiao B, Basu A, Bender MA, Hankins J, Ramsey S, Devine B. Quach D, et al. Among authors: jiao b. Expert Rev Pharmacoecon Outcomes Res. 2022 Sep;22(6):891-911. doi: 10.1080/14737167.2022.2060823. Epub 2022 Apr 18. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35363602 Free PMC article.

8

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.

Baldwin Z, Jiao B, Basu A, Roth J, Bender MA, Elsisi Z, Johnson KM, Cousin E, Ramsey SD, Devine B. Baldwin Z, et al. Among authors: jiao b. Pharmacoecon Open. 2022 Jul;6(4):469-481. doi: 10.1007/s41669-022-00330-w. Epub 2022 Apr 26. Pharmacoecon Open. 2022. PMID: 35471578 Free PMC article.

9

Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease.

Johnson KM, Jiao B, Bender MA, Ramsey SD, Devine B, Basu A. Johnson KM, et al. Among authors: jiao b. PLoS One. 2022 Apr 28;17(4):e0267448. doi: 10.1371/journal.pone.0267448. eCollection 2022. PLoS One. 2022. PMID: 35482721 Free PMC article.

10

Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance.

Johnson KM, Jiao B, Ramsey SD, Bender MA, Devine B, Basu A. Johnson KM, et al. Among authors: jiao b. Blood Adv. 2023 Feb 14;7(3):365-374. doi: 10.1182/bloodadvances.2021006281. Blood Adv. 2023. PMID: 35575558 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

952 results

Search Page

Filters